Ekso Bionics Holdings Stock Price Prediction

EKSO Stock  USD 0.69  0.03  4.03%   
As of today, the relative strength index (RSI) of Ekso Bionics' share price is approaching 35 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Ekso Bionics, making its price go up or down.

Oversold Vs Overbought

35

 
Oversold
 
Overbought
The successful prediction of Ekso Bionics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Ekso Bionics Holdings, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Ekso Bionics' stock price prediction:
EPS Estimate Next Quarter
(0.08)
Wall Street Target Price
5.5
EPS Estimate Current Quarter
(0.10)
Quarterly Revenue Growth
(0.10)
Using Ekso Bionics hype-based prediction, you can estimate the value of Ekso Bionics Holdings from the perspective of Ekso Bionics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Ekso Bionics to buy its stock at a price that has no basis in reality. In that case, they are not buying Ekso because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Ekso Bionics after-hype prediction price

    
  USD 0.76  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Ekso Bionics Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ekso Bionics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.142.786.61
Details
Naive
Forecast
LowNextHigh
0.010.704.53
Details
2 Analysts
Consensus
LowTargetHigh
8.199.009.99
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Ekso Bionics After-Hype Price Prediction Density Analysis

As far as predicting the price of Ekso Bionics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ekso Bionics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ekso Bionics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Ekso Bionics Estimiated After-Hype Price Volatility

In the context of predicting Ekso Bionics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ekso Bionics' historical news coverage. Ekso Bionics' after-hype downside and upside margins for the prediction period are 0.04 and 4.59, respectively. We have considered Ekso Bionics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.69
0.76
After-hype Price
4.59
Upside
Ekso Bionics is risky at this time. Analysis and calculation of next after-hype price of Ekso Bionics Holdings is based on 3 months time horizon.

Ekso Bionics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Ekso Bionics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ekso Bionics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ekso Bionics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.65 
3.85
  0.04 
  0.25 
8 Events / Month
9 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.69
0.76
5.56 
6,417  
Notes

Ekso Bionics Hype Timeline

Ekso Bionics Holdings is currently traded for 0.69. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of 0.25. Ekso is projected to increase in value after the next headline, with the price projected to jump to 0.76 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 5.56%, whereas the daily expected return is currently at -0.65%. The volatility of related hype on Ekso Bionics is about 993.98%, with the expected price after the next announcement by competition of 0.94. Ekso Bionics Holdings currently holds about 31.91 M in cash with (12.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next projected press release will be in about 8 days.
Check out Ekso Bionics Basic Forecasting Models to cross-verify your projections.

Ekso Bionics Related Hype Analysis

Having access to credible news sources related to Ekso Bionics' direct competition is more important than ever and may enhance your ability to predict Ekso Bionics' future price movements. Getting to know how Ekso Bionics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ekso Bionics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
PDEXPro Dex 1.09 11 per month 4.33  0.21  9.99 (9.00) 28.08 
CLPBYColoplast A 0.00 0 per month 0.00 (0.17) 1.96 (2.63) 5.64 
OPSSFOpsens Inc 0.00 0 per month 2.41  0.04  5.50 (4.58) 19.98 
SAUHYStraumann Holding AG 0.00 0 per month 0.00 (0.16) 3.19 (4.38) 12.55 
NEPHNephros(0.03)6 per month 0.00 (0.18) 2.74 (4.09) 8.78 
INFUInfuSystems Holdings 0.34 11 per month 2.69  0.14  7.64 (4.81) 22.10 
POCIPrecision Optics,(0.21)6 per month 4.06 (0.01) 7.48 (6.99) 18.59 
MLSSMilestone Scientific(0.04)8 per month 0.00 (0.12) 5.56 (7.89) 27.59 
FEMYFemasys 0.04 9 per month 3.46 (0.02) 6.56 (6.35) 22.44 
LMATLeMaitre Vascular 5.62 8 per month 1.23  0.11  3.15 (2.19) 10.31 
UTMDUtah Medical Products(0.90)8 per month 0.00 (0.15) 1.17 (1.82) 7.07 
GMVDG Medical Innovations 0.01 1 per month 0.00 (0.15) 5.26 (9.09) 36.17 
ATRIATRION(0.10)7 per month 0.00 (0.13) 0.94 (1.35) 6.29 
GCTKGlucoTrack 0.01 6 per month 0.00 (0.19) 10.40 (13.89) 90.86 
AKYAAkoya Biosciences(0.02)7 per month 0.00 (0.02) 9.32 (4.96) 40.94 

Ekso Bionics Additional Predictive Modules

Most predictive techniques to examine Ekso price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ekso using various technical indicators. When you analyze Ekso charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Ekso Bionics Predictive Indicators

The successful prediction of Ekso Bionics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ekso Bionics Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ekso Bionics based on analysis of Ekso Bionics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ekso Bionics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ekso Bionics's related companies.
 2023 2024 (projected)
Dividend Yield0.130.11
Price To Sales Ratio1.91.8

Story Coverage note for Ekso Bionics

The number of cover stories for Ekso Bionics depends on current market conditions and Ekso Bionics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ekso Bionics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ekso Bionics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Ekso Bionics Short Properties

Ekso Bionics' future price predictability will typically decrease when Ekso Bionics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ekso Bionics Holdings often depends not only on the future outlook of the potential Ekso Bionics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ekso Bionics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding13.9 M
Cash And Short Term Investments8.6 M
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Check out Ekso Bionics Basic Forecasting Models to cross-verify your projections.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
1.004
Quarterly Revenue Growth
(0.10)
Return On Assets
(0.24)
Return On Equity
(0.74)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.